Developing better methods to create carbohydrates and glycoconjugates for health applications
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
This study is working on making it easier and more effective to create important sugars and sugar-related compounds that our bodies need, which could help us better understand and treat certain diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11237945 on NIH RePORTER |
What this research studies
This research focuses on improving the chemical methods used to synthesize carbohydrates and glycoconjugates, which are essential for many biological processes. By addressing challenges related to the hydroxyl groups in carbohydrates, the research aims to create more efficient and selective synthesis techniques. These advancements could lead to better understanding and therapeutic applications of carbohydrates in treating diseases. The project will explore various functionalization methods and glycosidic linkages to enhance carbohydrate synthesis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from carbohydrate-based therapies, such as metabolic disorders or diseases involving glycosylation defects.
Not a fit: Patients with conditions unrelated to carbohydrate metabolism or those who do not require carbohydrate-based treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for diseases by improving the development of carbohydrate-based therapies.
How similar studies have performed: Previous research has shown promise in developing selective carbohydrate synthesis methods, indicating potential for success in this area.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Tang, Weiping — University of Wisconsin-Madison
- Study coordinator: Tang, Weiping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.